Patents by Inventor Lorie A. Ellis

Lorie A. Ellis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150119464
    Abstract: Disclosed are compositions and methods for treating or preventing dementia and pre-dementia-related conditions and/or symptoms or characteristics of such conditions.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 30, 2015
    Inventor: Lorie A. Ellis
  • Publication number: 20090215896
    Abstract: A method of measuring Reelin as a biomarker, to non-destructively assess or predict DHA levels in the brain and in other, currently inaccessible or difficult-to-access, key components of the central nervous system (CNS) is described. Also described is a method to prevent, delay the onset of, or treat Reelin deficiency or dysfunction and/or a disease or condition associated with Reelin deficiency or dysfunction, comprising administering to a patient diagnosed with or suspected of having a Reelin deficiency or dysfunction an amount of a PUFA, and particularly an omega-3 PUFA, and more particularly, docosahexaenoic acid (DHA) or a precursor or source thereof, to compensate for the effects of Reelin deficiency or dysfunction in the patient.
    Type: Application
    Filed: January 19, 2005
    Publication date: August 27, 2009
    Applicant: MARTEK BIOSCIENCES CORPORATION
    Inventors: John P. Morseman, Mark W. Moss, Lorie A. Ellis
  • Publication number: 20080234377
    Abstract: Disclosed are compositions and methods for treating or preventing dementia and pre-dementia-related conditions and/or symptoms or characteristics of such conditions.
    Type: Application
    Filed: March 23, 2007
    Publication date: September 25, 2008
    Applicant: MARTEK BIOSCIENCES CORPORATION
    Inventor: Lorie A. Ellis